1. Home
  2. RVSN vs MBRX Comparison

RVSN vs MBRX Comparison

Compare RVSN & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rail Vision Ltd.

RVSN

Rail Vision Ltd.

HOLD

Current Price

$0.32

Market Cap

20.9M

Sector

N/A

ML Signal

HOLD

Logo Moleculin Biotech Inc.

MBRX

Moleculin Biotech Inc.

HOLD

Current Price

$3.30

Market Cap

8.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVSN
MBRX
Founded
2016
2015
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.9M
8.6M
IPO Year
2022
2016

Fundamental Metrics

Financial Performance
Metric
RVSN
MBRX
Price
$0.32
$3.30
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$105.50
AVG Volume (30 Days)
722.9K
621.5K
Earning Date
02-03-2026
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$776,000.00
N/A
Revenue This Year
$28.46
N/A
Revenue Next Year
$755.09
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.27
$3.13
52 Week High
$2.50
$91.25

Technical Indicators

Market Signals
Indicator
RVSN
MBRX
Relative Strength Index (RSI) 43.03 45.43
Support Level $0.33 $3.13
Resistance Level $0.38 $4.24
Average True Range (ATR) 0.03 0.40
MACD -0.00 -0.33
Stochastic Oscillator 28.27 7.76

Price Performance

Historical Comparison
RVSN
MBRX

About RVSN Rail Vision Ltd.

Rail Vision Ltd is a development-stage technology company that is engaged in the design, development, and assembly of railway detection systems designed to solve the challenges in railway operational safety, efficiency, and predictive maintenance. Its railway detection systems include different types of cameras, including optics, visible light spectrum cameras (video), and thermal cameras that transmit data to a ruggedized onboard computer which is designed to be suitable for the rough environment of a train's locomotive. It has developed its railway detection and systems to save lives, increase efficiency, and dramatically reduce expenses for the railway operator.

About MBRX Moleculin Biotech Inc.

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.

Share on Social Networks: